ES2063266T3 - 4,5,6,11-tetrahidrobenzo(6,7)cicloocta(1,2-b)tiofen-6,11-iminas y 6,11-dihidrobenzo(6,7)cicloocta(1,2-b)tiofen-6,11-iminas. - Google Patents

4,5,6,11-tetrahidrobenzo(6,7)cicloocta(1,2-b)tiofen-6,11-iminas y 6,11-dihidrobenzo(6,7)cicloocta(1,2-b)tiofen-6,11-iminas.

Info

Publication number
ES2063266T3
ES2063266T3 ES90305716T ES90305716T ES2063266T3 ES 2063266 T3 ES2063266 T3 ES 2063266T3 ES 90305716 T ES90305716 T ES 90305716T ES 90305716 T ES90305716 T ES 90305716T ES 2063266 T3 ES2063266 T3 ES 2063266T3
Authority
ES
Spain
Prior art keywords
iminas
cicloocta
tiofen
compounds
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90305716T
Other languages
English (en)
Inventor
Ralph P Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2063266T3 publication Critical patent/ES2063266T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Luminescent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

EL PRESENTE INVENTO SE REFIERE A LOS COMPUESTOS DE FORMULA FIG EN DONDE LA LINEA QUEBRADA REPRESENTA A UN ENLACE OPCIONAL, R1 Y R4 SON HIDROGENO O C1 A C6 ALQUIL, Y R2 Y R3 SON HIDROGENO, C1 A C6 ALQUIL, HALOGENO, C1 A C6 ALCOXI O C1 A C6 ALQUILTIO, Y A SALES DERIVADAS FARMACEUTICAMENTE ACEPTABLES, A COMPUESTOS FARMACEUTICOS CONTENIENDO LOS MISMOS, A METODOS DE PREPARACION DE LOS ANTERIORES COMPUESTOS, Y A NUEVOS INTERMEDIARIOS PARA LA PREPARACION DE LOS ANTERIORES COMPUESTOS. ESTOS COMPUESTOS SON UTILES COMO AGENTES EN LA PREVENCION DE LOS DAÑOS NEURONALES EN EL CEREBRO QUE SIGUEN A LA ISQUEMIA CEREBRAL, Y DURANTE LA PROGRESION DEL SINDROME DE ALZHEIMER, Y TAMBIEN COMO ANTICONVULSIVOS.
ES90305716T 1989-06-01 1990-05-25 4,5,6,11-tetrahidrobenzo(6,7)cicloocta(1,2-b)tiofen-6,11-iminas y 6,11-dihidrobenzo(6,7)cicloocta(1,2-b)tiofen-6,11-iminas. Expired - Lifetime ES2063266T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/002387 WO1990015060A1 (en) 1989-06-01 1989-06-01 4,5,6,11-TETRAHYDROBENZO[6,7]CYCLOOCTA[1,2-b]THIOPHEN-6,11-IMINES AND 6,11-DIHYDROBENZO[6,7]CYCLOOCTA[1,2-b]THIOPHEN-6,11-IMINES

Publications (1)

Publication Number Publication Date
ES2063266T3 true ES2063266T3 (es) 1995-01-01

Family

ID=22215050

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90305716T Expired - Lifetime ES2063266T3 (es) 1989-06-01 1990-05-25 4,5,6,11-tetrahidrobenzo(6,7)cicloocta(1,2-b)tiofen-6,11-iminas y 6,11-dihidrobenzo(6,7)cicloocta(1,2-b)tiofen-6,11-iminas.

Country Status (11)

Country Link
EP (1) EP0400916B1 (es)
JP (1) JPH0662630B2 (es)
AT (1) ATE113950T1 (es)
CA (1) CA2017911A1 (es)
DE (1) DE69013983T2 (es)
DK (1) DK0400916T3 (es)
ES (1) ES2063266T3 (es)
FI (1) FI98462C (es)
IE (1) IE64909B1 (es)
PT (1) PT94205B (es)
WO (1) WO1990015060A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196415A (en) * 1989-05-09 1993-03-23 The United States Of America As Represented By The Department Of Health And Human Services 5-aminocarbonyl-5H-dibenzo[a.d]cyclohepten-5,10-imines for treatment of epilepsy and cocaine addiction
US5260309A (en) * 1989-06-01 1993-11-09 Pfizer Inc. 4,5,6,11-tetrahydrobenzo [6,7] cycloocta [1,2-b]thiophen-6,11-imines and 6,11-dihydrobenzo [6,7] cycloocta [1,2-b] thiophen-6,11-imines
GB9002834D0 (en) * 1990-02-08 1990-04-04 Ici America Inc Compounds
US6413410B1 (en) 1996-06-19 2002-07-02 Lifescan, Inc. Electrochemical cell

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3816455A (en) * 1971-04-23 1974-06-11 Mcneilab Inc Certain benzothiepino-indoles and indoline-thiochromans
US4112110A (en) * 1974-02-22 1978-09-05 Ciba-Geigy Corporation Oxygenated azatetracyclic compounds
US4414154A (en) * 1977-09-19 1983-11-08 Merck & Co. Inc. Dibenzo[a,d]cycloocten-5,12-imines
NL7808848A (nl) * 1977-09-19 1979-03-21 Merck & Co Inc Dibenzoa.dcyclo-octeen-5.12-(en 6.12)-iminen.
US4252810A (en) * 1978-11-15 1981-02-24 Merck & Co., Inc. 9,10-Dihydro-4H-benzo[4,5]cyclohepta [1,2-b]thiophen-4,9-imines

Also Published As

Publication number Publication date
FI915646A0 (fi) 1991-11-29
WO1990015060A1 (en) 1990-12-13
CA2017911A1 (en) 1990-12-01
PT94205A (pt) 1991-02-08
EP0400916B1 (en) 1994-11-09
IE901951L (en) 1990-12-01
JPH0320278A (ja) 1991-01-29
PT94205B (pt) 1997-01-31
DE69013983T2 (de) 1995-03-16
EP0400916A2 (en) 1990-12-05
FI98462C (fi) 1997-06-25
DK0400916T3 (da) 1994-12-05
JPH0662630B2 (ja) 1994-08-17
IE64909B1 (en) 1995-09-20
ATE113950T1 (de) 1994-11-15
EP0400916A3 (en) 1991-11-27
FI98462B (fi) 1997-03-14
DE69013983D1 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
DE69008142D1 (de) 4-Substituierten Imidazolen zur Senkung des intraokularen Druckes.
MX13270A (es) Procedimiento para la preparacion de derivados de 4-aminopiridina
DK213290D0 (da) Treatment of cerebrovascular disorders
YU224790A (sh) Aminokarbonil karbamati, sorodni fizostigminu/in postopek za njihovo pripravo in njihova uporaba kot zdravila
ES2046641T3 (es) Composicion antitumoral.
ES2063266T3 (es) 4,5,6,11-tetrahidrobenzo(6,7)cicloocta(1,2-b)tiofen-6,11-iminas y 6,11-dihidrobenzo(6,7)cicloocta(1,2-b)tiofen-6,11-iminas.
NZ232207A (en) Dihydrobenz(c)acridine derivatives and pharmaceutical compositions
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
ZA891769B (en) Heterocyclic compounds
DK0420224T3 (da) Anthihepatopatisk middel
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
BR9902049A (pt) Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina.
ATE96144T1 (de) 2-aminoacetamid derivate.
IL110369A0 (en) Pharmaceutical compositions for the prevention and/or treatment of gastrointestinal diseases including ulcer
FI933652A (fi) Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 400916

Country of ref document: ES